Dyne Therapeutics Inc (NASDAQ:DYN)
| 14.01 Delayed Data As of Feb 03 |  0.00 / 0.00%Today’s Change | 4.30 Today|||52-Week Range 15.63 | +20.88% Year-to-Date |
Latest DYN News | Press Releases
No recent news for Dyne Therapeutics Inc.
Today’s Trading
| Previous close | 14.01 |
| Today’s open | 14.86 |
| Day’s range | 13.38 - 14.23 |
| Volume | 6,092 |
| Average volume (3 months) | 296,974 |
| Market cap | $730.3M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +28.95% |
| Earnings growth (this year) | -15.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.96 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | -$0.87 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$149.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
